Shareholding disclosure

Camber Capital Management LP

Declared position

3.78%

Threshold

Crossed upwards

Timeline

Published

05.11.2020

Transaction

28.10.2020

Voting rights breakdown

Voting rights acquired3.78%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAKB300051

Beneficial owner

Camber Capital Management LP

Declared address

Camber Capital Management LP, Boston, MA 02199

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Camber Capital Management LP

Molecular Partners AG05.11.2020TAKB300051

Disclosure summary

Camber Capital Management LP disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 05.11.2020, at 3.78% of voting rights. Notice category: Single shareholder.

Disclosed position

3.78%

Voting rights acquired

Voting rights acquired3.78%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Camber Capital Management LP disclosed a holding in Molecular Partners AG, published on 05.11.2020.

Publication date05.11.2020

Transaction date28.10.2020

Issuing companyMolecular Partners AG

Beneficial ownerCamber Capital Management LP

Declared addressCamber Capital Management LP, Boston, MA 02199

CategorySingle shareholder

Voting rights acquired3.78%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAKB300051

Source: SIX Exchange Regulation · Publication date: 05.11.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open